A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
about
OVCA2 is downregulated and degraded during retinoid-induced apoptosisIdentification of the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-ribosylating toxins on translation elongation factor 2Diphthamide biosynthesis requires an organic radical generated by an iron-sulphur enzymeIdentification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53The biosynthesis and biological function of diphthamideOvca1 regulates cell proliferation, embryonic development, and tumorigenesisGene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2.Reconstitution of diphthine synthase activity in vitro.Genomic aberrations in borderline ovarian tumors.Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse.A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene.Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.Unique modifications of translation elongation factors.MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1.Mechanistic understanding of Pyrococcus horikoshii Dph2, a [4Fe-4S] enzyme required for diphthamide biosynthesis.A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome.
P2860
Q24295235-C144EE95-A287-4B6A-9879-1F43560E115EQ24307016-19D5EC7B-A7DF-41FC-B841-1B896AC000CCQ24624375-8B71C61C-6AFB-483A-80FE-11A4CA7EB4C0Q28143652-35507332-B4E3-45F0-89B6-E488E2E241F4Q28297199-685D78E7-1A44-4BB6-B36B-778AB9911C4AQ28586049-57EF18C9-0489-4154-B911-15EE16FCFA4AQ33210643-481C87AE-4DE0-49DD-AC93-B77BA7AEE67AQ33704218-903DE744-20F7-4F32-A12F-7A22BE2EE3B8Q33728834-0D7B129C-DEE6-4007-B16A-3F0FBE9CFF58Q35194904-B5CC8FE9-FB89-46BE-A6CB-10BEA3220192Q36796947-DC3D43FA-38A9-4F80-8F85-E8473B796BCEQ37347191-997122D1-0174-4AE3-8CF4-050132620EA1Q37882043-C904E7A0-2D4A-4B23-8848-800658454FA6Q39020346-469CF454-76C0-4DC3-A846-35F994D66088Q42125245-309B82AE-725A-45BB-90A7-4BBCD550C81AQ47128416-A4337113-E817-490C-94CD-0614B1E9EADFQ47981822-EB9CE555-A837-46A6-A729-FE9AB1F654CD
P2860
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@ast
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@en
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@nl
type
label
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@ast
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@en
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@nl
prefLabel
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@ast
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@en
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@nl
P2093
P1433
P1476
A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3
@en
P2093
L L Deaven
M R Zeigler
N J Phillips
P356
10.1016/0304-3835(96)04169-9
P407
P577
1996-04-19T00:00:00Z